02/27
Headlines

Intrexon Corp

Biotech Volatile Stocks: Intrexon Corp (NYSE:XON), Spectrum Pharmaceuticals, Inc. (NASDAQ:SPPI), Sangamo Biosciences, Inc. (NASDAQ:SGMO), Osiris Therapeutics, Inc. (NASDAQ:OSIR)

Jayne Crisman02 mins

Intrexon Corp (NYSE:XON) COO Krish Krishnan purchased 20,900 shares of Intrexon Corp (NYSE:XON) stock in a transaction that occurred on Friday, May 9th. The stock was purchased at an average price of $14.21 per share, for a total transaction of $296,989.00. Following the purchase, the chief operating officer now directly owns 20,900 shares in the…

Read More

Biotech Gainers: MannKind Corporation (NASDAQ:MNKD), Celldex Therapeutics (NASDAQ:CLDX), Dendreon Corporation (NASDAQ:DNDN), Intrexon Corp (NYSE:XON)

Mark DeFrance02 mins

MannKind Corp. (NASDAQ: MNKD) was raised to Neutral from Underweight by Piper Jaffray. MannKind Corporation (NASDAQ:MNKD) stock performance was 6.53% in last session and finished the day at $7.01. Traded volume was 16.68million shares in the last session and the average volume of the stock remained 10.11million shares. The beta of the stock remained 1.40….

Read More

Hot Stocks: FireEye Inc (NASDAQ:FEYE), Synageva BioPharma Corp (NASDAQ:GEVA), Intrexon Corp (NYSE:XON), Puma Biotechnology Inc (NYSE:PBYI)

Chris Lewis02 mins

FireEye, Inc. (NASDAQ: FEYE) filed a registration with the U.S. SEC to sell, from time to time, up to 13,282,316 shares of its Common Stock on behalf of Selling Shareholders. FireEye Inc (NASDAQ:FEYE) stock performance was 5.05% in last session and finished the day at $50.57. Traded volume was 6.04million shares in the last session…

Read More

Healthcare Most Volatile: Idenix Pharmaceuticals Inc (NASDAQ:IDIX), OXiGENE Inc (NASDAQ:OXGN), Intrexon (NYSE:XON), Enzon Pharmaceuticals (NASDAQ:ENZN)

John Bellich02 mins

Idenix Pharmaceuticals (NASDAQ:IDIX) , which had its hepatitis C drugs put on clinical hold because it had a similar structure to Bristol-Myers Squibb’s BMS-986094, which had serious cardiac side effects. Idenix Pharmaceuticals Inc (NASDAQ:IDIX) stock performance was -6.45% in last session and finished the day at $7.11. Traded volume was 3,306,727 million shares in the…

Read More
FB Nasdaq FB Facebook

Biotech Most Volatile Stocks: Opexa Therapeutics (NASDAQ:OPXA), Intrexon (NYSE:XON), Chimerix (NASDAQ:CMRX), NewLink Genetics (NASDAQ:NLNK)

Colin Pettis02 mins

On March 5, 2014, Opexa Therapeutics, Inc. (NASDAQ:OPXA) entered into a First Amendment to Sales Agreement (the “First Amendment”) with Meyers Associates, L.P. (doing business as Brinson Patrick, a division of Meyers Associates, L.P.) (the “New Sales Manager”) and Brinson Patrick Securities Corporation (the “Original Sales Manager”). Pursuant to the First Amendment, the Sales Agreement…

Read More